← back to search

Ledu Zhou

Central South University · CN
Area of research
Hepatology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Ferroptosis and cancer prognosis, Cancer Genomics and Diagnostics, and Cholangiocarcinoma and Gallbladder Cancer Studies.
h-index
24
citations
2,567
works
71
NIH funding
primary concept
email

Recent publications

Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial
˜The œLancet. Gastroenterology & hepatology 2025cited by 35position: middledoi
Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)
Liver Cancer 2023cited by 435position: middledoi
Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study
BMC Cancer 2023cited by 27position: middledoi
Systemic therapy with or without transcatheter intra-arterial therapies for unresectable hepatocellular carcinoma: a real-world, multi-center study
Frontiers in Immunology 2023cited by 12position: middledoi
Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)
HepatoBiliary Surgery and Nutrition 2022cited by 197position: middledoi
Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study
Liver Cancer 2022cited by 49position: middledoi
Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition)
Liver Cancer 2022cited by 20position: middledoi
A DNA nanostructured aptasensor for the sensitive electrochemical detection of HepG2 cells based on multibranched hybridization chain reaction amplification strategy
Biosensors and Bioelectronics 2018cited by 87position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Kui Wang · Nanchang University2 papers (2023–2023)Yongjun Chen · Ruijin Hospital2 papers (2023–2023)Xiao‐Dong Zhu · Qingdao University of Science and Technology2 papers (2023–2023)Hui‐Chuan Sun · Jiangsu University2 papers (2023–2023)Tianqiang Song · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2023–2023)Huasheng Huang · Guangzhou University of Chinese Medicine1 papers (2023–2023)Haitao Zhao · Shenyang Pharmaceutical University1 papers (2023–2023)Shunli Shen · Sun Yat-sen University1 papers (2023–2023)Kuan Hu · China Pharmaceutical University1 papers (2023–2023) · 1 papers (2023–2023)Feng Ye · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2023–2023)Jianwei Liu · Xuzhou Medical College1 papers (2023–2023)Zhong Chen · Nantong University1 papers (2023–2023)Wei Zhang · Chongqing Public Health Medical Center1 papers (2023–2023)Jia Fan · China Medical University1 papers (2023–2023)Hongzhi Liu · South China Agricultural University1 papers (2023–2023)Yu Zhang · Qinghai University Affiliated Hospital1 papers (2023–2023)Liang Chen · Sun Yat-sen University1 papers (2018–2018)Lingli Chen · Nanjing Agricultural University1 papers (2023–2023)Yuan Ji · Sun Yat-sen University1 papers (2023–2023)